BinaxNOW COVID-19 Antigen Self Test, 1 Pack, 10 Tests Total, COVID Test With 15-Minute Results Without Sending to a Lab, Easy to Use at Home

Description

Feeling Sick? Act Quick! BinaxNOW™ COVID-19 Antigen Self Test, now available in a 10-count multi-pack. This rapid antigen test from Abbott detects active COVID-19 infection in adults and kids as young as 2 years old. FDA authorized, 15-minute rapid COVID-19 self test delivers reliable results. It utilizes the same technology used by doctors to test for COVID-19. 10 Test Kit Contains: 10 BinaxNOW COVID-19 Test Cards, 10 Nasal Swabs and 10 Reagent Bottles and instructions for use. * BinaxNOW™ 10 Test Bulk Pack: This multi-pack includes 10 at-home tests designed to detect active infection. * BinaxNOW™ Self Test uses the SAME TECHNOLOGY USED BY DOCTORS to test for COVID-19. * Detects multiple COVID-19 variants, including Delta and Omicron* * FAST RESULTS: FDA Authorized 15-Minute Self Test: Convenient COVID-19 at-home test provides fast, reliable results in 15 minutes, results anytime, anywhere; no need for a prescription or send to a lab. * RELIABLE and EASY-TO-USE: Requires just a shallow nasal swab that you can do yourself; includes easy-to-follow instructions. * FOR AGES 2 and ABOVE: COVID-19 test suitable for kids, when administered by an adult, and for all people 15 and older to self-administer. * DETECTS ACTIVE COVID-19 INFECTION: Includes 10 rapid tests that are indicated for serial testing. Serial (or repeat) testing should be performed in individuals with negative results at least twice over three days (with at least 48 hours between tests) for symptomatic individuals and three times over five days (with at least 48 hours between tests) for asymptomatic individuals. * *Abbott conducted an analysis of the detection of multiple SARS-CoV-2 strains and predicts no impact to the performance of our BinaxNOW™ COVID-19 Antigen Self Test. * The BinaxNOW™ COVID-19 Antigen Self Test has not been FDA cleared or approved. It has been authorized by the FDA under an emergency use authorization. It has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens, and are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner. © 2023 Abbott. All rights reserved. BinaxNOW is a trademark of Abbott and used with permission. * Any photos displayed are for illustrative purposes only. Any person depicted in such photos is a model.